Hui-Juan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hui-Juan Li has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bin Wang
Guangdong Institute of Intelligence Science and Technology, Zhuhai, China
1 shared publication - Chang-Xin Li
Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China
1 shared publication Dandan Zheng
Guangdong Institute of Intelligence Science and Technology
1 shared publication- Jian-Lin Liang
Department of Neurology, Headache Center, The First Hospital of Shanxi Medical University, 030001 Taiyuan, Shanxi, China
1 shared publication - Lan Bao
Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, the Chinese Academy of Sciences Center for Excellence in Molecular Cell Science, University of Chinese Academy of Sciences, Chinese Academy of Sciences
1 shared publication - Lingqian Wu
Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (27)
Disruption of dynactin complex function in intellectual disability
Intellectual disability (ID) is a highly prevalent condition affecting approximately 200 millions of people worldwide, characterized by impaired cognitive function. Dynactin complex consists of multiple protein subunits and is required for intracellular trafficking and synaptic homeostasis in developing and mature neurons. Here, we identify deleterious variants of dynactin subunit 4 (DCTN4) in ID pedigrees. DCTN4 ablation in mice results in altered neuronal positioning and apoptosis in neural progenitor cells. Notably, mice carrying the ID-linked DCTN4 variant exhibit cognitive deficits with impaired dendritic development. Cortical neurons with DCTN4 deficiency or variant show reduced levels of various dynactin subunits, suggesting that deficits in dynactin complex affects synaptic function. Furthermore, disruption of the DCTN4–JIP3 complex impairs lysosomal transport and dendritic development as well as synaptic development. Importantly, we showed that damaging variants in another dynactin subunit DCTN2 also disrupt neuronal positioning, reinforcing the critical role of dynactin complex in neurodevelopment and ID pathogenesis. These findings illustrate dysfunctional dynactin complex as a previously unrecognized disease mechanism of ID.
- 30 June 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (27)
Open AccessDisruption of dynactin complex function in intellectual disability
Intellectual disability (ID) is a highly prevalent condition affecting approximately 200 millions of people worldwide, characterized by impaired cognitive function. Dynactin complex consists of multiple protein subunits and is required for intracellular trafficking and synaptic homeostasis in developing and mature neurons. Here, we identify deleterious variants of dynactin subunit 4 (DCTN4) in ID pedigrees. DCTN4 ablation in mice results in altered neuronal positioning and apoptosis in neural progenitor cells. Notably, mice carrying the ID-linked DCTN4 variant exhibit cognitive deficits with impaired dendritic development. Cortical neurons with DCTN4 deficiency or variant show reduced levels of various dynactin subunits, suggesting that deficits in dynactin complex affects synaptic function. Furthermore, disruption of the DCTN4–JIP3 complex impairs lysosomal transport and dendritic development as well as synaptic development. Importantly, we showed that damaging variants in another dynactin subunit DCTN2 also disrupt neuronal positioning, reinforcing the critical role of dynactin complex in neurodevelopment and ID pathogenesis. These findings illustrate dysfunctional dynactin complex as a previously unrecognized disease mechanism of ID.
- Open Access
- 31 October 2024
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 23 (11) , 201
Lentivirus-Mediated Missense Mutation in HtrA1 Leads to Activation of the TGF-β/Smads Pathway and Increased Apoptosis of Mouse Brain Microvascular Endothelial Cells via the Oxidative Stress Pathway
Background: The aim of this study was to investigate the possible molecular mechanisms underlying cerebral small vessel disease caused by a missense mutation in the high-temperature serine peptidase A1 gene, HtrA1 (NM_002775.4, Exon4, c.905G>A, p.Arg302Gln). Stable strain models were constructed using wild-type and mutant HtrA1 overexpression lentiviral vectors to infect mouse brain microvascular endothelial cells (bEnd.3 cells). Methods: HtrA1 mRNA and protein expression were analyzed by Western blot and quantitative real-time polymerase chain reaction. Western blot technique was also used to evaluate the expression of transforming growth factor (TGF)-β/Smads-related signaling pathway proteins and the oxidative stress pathway protein nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4). The level of reactive oxygen species (ROS) was evaluated using dichloro-dihydro-fluorescein diacetate (DCFH-DA) fluorescent probes. Results: HtrA1 mRNA and protein expression levels were found to be decreased in mutant cells, whereas the levels of ROS, the TGF-β/Smads proteins, and the caspase3 and cleaved-caspase3 apoptotic proteins were increased. Conclusions: Lentivirus-mediated missense mutation in HtrA1 leads to activation of the TGF-β/Smads pathway and to increased apoptosis of mouse brain microvascular endothelial cells via the oxidative stress pathway. Further in vivo studies are required to explore the connections between different signaling pathways in animals, and to identify potential molecular targets for clinical therapy.
- 31 October 2024
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 23 (11) , 201
Open AccessLentivirus-Mediated Missense Mutation in HtrA1 Leads to Activation of the TGF-β/Smads Pathway and Increased Apoptosis of Mouse Brain Microvascular Endothelial Cells via the Oxidative Stress Pathway
Background: The aim of this study was to investigate the possible molecular mechanisms underlying cerebral small vessel disease caused by a missense mutation in the high-temperature serine peptidase A1 gene, HtrA1 (NM_002775.4, Exon4, c.905G>A, p.Arg302Gln). Stable strain models were constructed using wild-type and mutant HtrA1 overexpression lentiviral vectors to infect mouse brain microvascular endothelial cells (bEnd.3 cells). Methods: HtrA1 mRNA and protein expression were analyzed by Western blot and quantitative real-time polymerase chain reaction. Western blot technique was also used to evaluate the expression of transforming growth factor (TGF)-β/Smads-related signaling pathway proteins and the oxidative stress pathway protein nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4). The level of reactive oxygen species (ROS) was evaluated using dichloro-dihydro-fluorescein diacetate (DCFH-DA) fluorescent probes. Results: HtrA1 mRNA and protein expression levels were found to be decreased in mutant cells, whereas the levels of ROS, the TGF-β/Smads proteins, and the caspase3 and cleaved-caspase3 apoptotic proteins were increased. Conclusions: Lentivirus-mediated missense mutation in HtrA1 leads to activation of the TGF-β/Smads pathway and to increased apoptosis of mouse brain microvascular endothelial cells via the oxidative stress pathway. Further in vivo studies are required to explore the connections between different signaling pathways in animals, and to identify potential molecular targets for clinical therapy.